Effects of autologous (OWN) platelet-poor plasma on prevention of bronchopleural fistula and lung damage in patients undergoing lung resectio

• Conditions: Bronchopleural fistula; MedDRA version: 14.1Level: PTClassification code 10053481Term: Bronchopleural fistulaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders; Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02]

• Registration Number: EUCTR2012-000397-30-ES
• Lead Sponsor: FUNDACIÓN CANARIA DE INVESTIGACIÓN Y SALUD (FUNCIS)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-10-15
• Last Update Posted: 25 February 2013

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

-Patients over 30 y/o
Tumor-free margins in the surgical specimen
-Patients who underwent pneumonectomy, lobectomy, or bilobectomy for lung cancer
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 100
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 200

Exclusion Criteria

-There is no upper age limit
-Infections prior to surgery (pleural empyema)
-Tumor-affected surgical margins

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified